Literature DB >> 9930668

Structural model of the catalytic domain of an enzyme with cell adhesion activity: human vascular adhesion protein-1 (HVAP-1) D4 domain is an amine oxidase.

T A Salminen1, D J Smith, S Jalkanen, M S Johnson.   

Abstract

Human vascular adhesion protein-1 (HVAP-1) is a multifunctional protein having at least two different cellular roles, functioning both as a lymphocyte-endothelial cell adhesion protein and as an enzyme with monoamine oxidase activity. HVAP-1 is a 180 kDa homodimeric glycoprotein consisting of a membrane-spanning domain and three predicted extracellular copper-containing amine oxidase domains. In HVAP-1 the extracellular domains are composed of a large domain D4, containing the active site and forming the interface of the dimer, while the smaller D2 and D3 domains surround the D4 dimer near the entrance to the active site. The structural model of the catalytic D4 domain of HVAP-1 reveals that all components necessary for enzymatic monoamine oxidase activity are indeed present within the HVAP-1 and pinpoints residues that may be key to substrate entry through a channel to the active site and residues likely to be involved in substrate specificity as well as structural features critical to dimer formation. Proper glycosylation is required for the cell adhesion function of HVAP-1 and the predicted location of the sugar units at the solvent-exposed surface suits this function well.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9930668     DOI: 10.1093/protein/11.12.1195

Source DB:  PubMed          Journal:  Protein Eng        ISSN: 0269-2139


  10 in total

Review 1.  Cell surface monoamine oxidases: enzymes in search of a function.

Authors:  S Jalkanen; M Salmi
Journal:  EMBO J       Date:  2001-08-01       Impact factor: 11.598

2.  Phosphonium compounds as new and specific inhibitors of bovine serum amine oxidase.

Authors:  Maria Luisa Di Paolo; Michele Lunelli; Marina Scarpa; Adelio Rigo
Journal:  Biochem J       Date:  2004-12-15       Impact factor: 3.857

3.  Human vascular adhesion protein-1 in smooth muscle cells.

Authors:  K Jaakkola; K Kaunismäki; S Tohka; G Yegutkin; E Vänttinen; T Havia; L J Pelliniemi; M Virolainen; S Jalkanen; M Salmi
Journal:  Am J Pathol       Date:  1999-12       Impact factor: 4.307

Review 4.  Ectoenzymes in leukocyte migration and their therapeutic potential.

Authors:  Marko Salmi; Sirpa Jalkanen
Journal:  Semin Immunopathol       Date:  2014-03-18       Impact factor: 9.623

5.  Crystal structure of the human vascular adhesion protein-1: unique structural features with functional implications.

Authors:  Tomi T Airenne; Yvonne Nymalm; Heidi Kidron; David J Smith; Marjo Pihlavisto; Marko Salmi; Sirpa Jalkanen; Mark S Johnson; Tiina A Salminen
Journal:  Protein Sci       Date:  2005-08       Impact factor: 6.725

6.  Interaction of rat lung SSAO with the novel 1-N-substituted thiocarbamoyl-3-substituted phenyl-5-(2-pyrolyl)-2-pyrazoline derivatives.

Authors:  S Yabanoglu; G Ucar; N Gokhan; U Salgin; A Yesilada; A A Bilgin
Journal:  J Neural Transm (Vienna)       Date:  2007-03-26       Impact factor: 3.575

7.  Amine oxidase substrates mimic several of the insulin effects on adipocyte differentiation in 3T3 F442A cells.

Authors:  E Fontana; J Boucher; L Marti; J M Lizcano; X Testar; A Zorzano; C Carpéné
Journal:  Biochem J       Date:  2001-06-15       Impact factor: 3.857

8.  Structure and inhibition of human diamine oxidase.

Authors:  Aaron P McGrath; Kimberly M Hilmer; Charles A Collyer; Eric M Shepard; Bradley O Elmore; Doreen E Brown; David M Dooley; J Mitchell Guss
Journal:  Biochemistry       Date:  2009-10-20       Impact factor: 3.162

9.  The unique substrate specificity of human AOC2, a semicarbazide-sensitive amine oxidase.

Authors:  Sam Kaitaniemi; Heli Elovaara; Kirsi Grön; Heidi Kidron; Janne Liukkonen; Tiina Salminen; Marko Salmi; Sirpa Jalkanen; Kati Elima
Journal:  Cell Mol Life Sci       Date:  2009-07-09       Impact factor: 9.261

Review 10.  SSAO/VAP-1 in Cerebrovascular Disorders: A Potential Therapeutic Target for Stroke and Alzheimer's Disease.

Authors:  Mercedes Unzeta; Mar Hernàndez-Guillamon; Ping Sun; Montse Solé
Journal:  Int J Mol Sci       Date:  2021-03-25       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.